Why the study?
No cardiovascular risk scores were based on data from Latin America and the Caribbean, and it was unknown how well European and North American scores represented true risk in this population.
Does the Globorisk-LAC risk score accurately predict fatal/non-fatal cardiovascular events in Latin American and Caribbean populations?
Does the Globorisk-LAC risk score accurately predict fatal/non-fatal cardiovascular events in Latin American and Caribbean populations?
The Globorisk-LAC risk score provides an internally validated tool with adequate discrimination and calibration for cardiovascular risk stratification in Latin American and Caribbean populations.
No takes yet. Share an insight, caveat, or question.
May aid CV risk stratification in LAC populations; leaves open external validation before clinical adoption.
A 2022 study studied this question.